GWAG
JAZZ icon

Garrett Wealth Advisory Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Garrett Wealth Advisory Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14
Closed -$1.79K – 357
2019
Q3 		$1.79K Buy
+14
New +$1.88K ﹤0.01% 588

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Garrett Wealth Advisory Group's JAZZ Position: Q4 2019 in Review

Garrett Wealth Advisory Group sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2019, closing a stake of 14 shares — an estimated $1.79K sold.

Garrett Wealth Advisory Group first reported a position in JAZZ in Q3 2019 and held it in 1 quarter. The position peaked at $1.79K in Q3 2019. 446 funds tracked by Wall St. Rank hold JAZZ as of Q4 2019.

  • Garrett Wealth Advisory Group reported no remaining Jazz Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Garrett Wealth Advisory Group sold 14 Jazz Pharmaceuticals shares in Q4 2019, an estimated $1.79K.
  • Garrett Wealth Advisory Group first reported a position in Jazz Pharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Garrett Wealth Advisory Group's Jazz Pharmaceuticals position peaked at $1.79K in Q3 2019.
  • 446 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2019.

Based on Garrett Wealth Advisory Group's 13F filing for Q4 2019, filed 28 Jan 2020.